Evidence map›Paper›PMID 32241913›Full record

ArticleThe Journal of biological chemistry2020

Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.

Vladimir Mekler, Konstantin Kuznedelov, Konstantin Severinov

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Engineered probiotics.Microbial cell factories · 2022
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Vladimir MeklerWaksman Institute of Microbiology, Rutgers, State University of New Jersey, Piscataway, New Jersey 08854 mekler@waksman.rutgers.edu.
Konstantin KuznedelovWaksman Institute of Microbiology, Rutgers, State University of New Jersey, Piscataway, New Jersey 08854.
Konstantin SeverinovWaksman Institute of Microbiology, Rutgers, State University of New Jersey, Piscataway, New Jersey 08854 severik@waksman.rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

The Function of Small RNA-Based viral Defense System in E. coli - Renewal 1R01GM104071 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI SEMENOVA, EKATERINA · 2013 to 2024
$3.9M
NIGMS NIH HHS R01 GM104071
6 · The paper itself

Abstract

The CRISPR/Cas9 nucleases have been widely applied for genome editing in various organisms. Cas9 nucleases complexed with a guide RNA (Cas9-gRNA) find their targets by scanning and interrogating the genomic DNA for sequences complementary to the gRNA. Recognition of the DNA target sequence requires a short protospacer adjacent motif (PAM) located outside this sequence. Given that the efficiency of target location may depend on the strength of interactions that promote target recognition, here we sought to compare affinities of different Cas9 nucleases for their cognate PAM sequences. To this end, we measured affinities of Cas9 nucleases from

Indexed as

CRISPR-Cas SystemsCRISPR-Associated Protein 9FrancisellaRNA, BacterialRNA, Guide, CRISPR-Cas SystemsStaphylococcus aureusStreptococcus pyogenesCas9 endonuclease Streptococcus pyogenesCas9 protein, Francisella novicidaCRISPR-Associated Protein 9RNA, BacterialRNA, Guide, CRISPR-Cas SystemsCas9CRISPR/CasDNA-binding proteinDNA–protein interactionfluorescencefluorescent Cas9 beacongenome editingRNA binding protein

Identifiers

PMID32241913
PMCPMC7212624
OpenAlexW3015098563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.